biostudies-literatureJohnson SRNHLBI NIH HHSAmerican College of Rheumatology1201-1213https://www.ebi.ac.uk/biostudies/studies/S-EPMC12646464biostudies-literatureUnknown76(8)<h4>Objective</h4>We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren disease.<h4>Methods</h4>We developed clinically relevant population, intervention, comparator, and outcomes questions related to screening and monitoring for ILD in patients with SARDs. A systematic literature review was performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology. A Voting Panel of interdisciplinary clinician experts and patients achieved consensus Arthritis & rheumatology (Hoboken, N.J.)2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.PMC12646464R01 HL169166R01 HL166290McMahan ZHNatalini JGGuyatt GSolomon JJMcDermott GCLee JSSaygin DAgarwal SKBolster MBWarrier ASingh NOldham JMHallowell RDomsic RTVaseer SBemiss BCorwin DSDematte D'Amico JEMakol AMerck SJHinze AMSummer RJiwrajka NLakin KSChami HAShapiro LAntin-Ozerkis DChung JHDellaripa PFFrech TMKim JSDoyle TJKanne JPChowdhary VHinchcliff MNesbitt KLim SYMirza RDGibbons FKJohnson SRAggarwal RJoerns EKKhanna DTurner ABernstein EJScholand MBSparks JAUhl SAssassi SJohnson CBuckley LGeorge MDVarga JTurgunbaev MAllen AFalardeau CMMatson SInjean PADanoff SKSharkey CDIvlev Ifalse2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.<h4>Objective</h4>We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren disease.<h4>Methods</h4>We developed clinically relevant population, intervention, comparator, and outcomes questions related to screening and monitoring for ILD in patients with SARDs. A systematic literature review was performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology. A Voting Panel of interdisciplinary clinician experts and patients achieved consensus 2024-01-01T00:00:00Z2024 Aug2026-06-05T19:15:03.374Z2026-05-20T03:14:14.71ZS-EPMC126464643897371410.1002/art.42860